NEC Baby Formula Lawsuit

Legal Support for Families of Premature Infants Diagnosed with NEC After Formula Feeding

Scientific research has shown a link between cow's milk-based baby formula and the risk of Necrotizing Enterocolitis (NEC) in premature infants. Popular infant formulas such as Similac and Enfamil, manufactured by Abbott Laboratories and Mead Johnson Nutrition, have been associated with a significantly higher risk of NEC when fed to preterm babies. At Injury Claim Center, we provide resources and legal guidance for families whose children developed NEC after receiving Similac or Enfamil in neonatal care. Our mission is to support those seeking answers and accountability.

What is NEC?

Necrotizing Enterocolitis (NEC) is a serious gastrointestinal disease that primarily affects premature and low birth weight infants. It causes inflammation and damage to the intestinal tissue, which may lead to infection, perforation, or the need for surgery. In severe cases, NEC can be fatal. While NEC has multiple contributing factors, research has identified a higher incidence of the condition in preterm infants who were fed cow's milk-based formulas, rather than human breast milk.

Find Out If You Qualify For A
NEC FORMULA LAWSUIT

Step 1 of 2

Concerns About Similac and Enfamil

Despite evidence linking cow's milk-based formula to an increased risk of NEC in premature infants, manufacturers have continued to market Similac and Enfamil for use in hospitals and NICUs without adequate warnings.

Key Concerns:

  • Studies have consistently shown that premature infants fed cow's milk formula are at a higher risk of developing NEC.
  • Leading health organizations recommend the use of human milk whenever possible for preterm babies.
  • Similac and Enfamil were promoted without sufficient disclosure of known NEC risks to healthcare providers or parents.

NEC Baby Formula Litigation

Families across the country are filing lawsuits alleging that formula manufacturers:

  • Failed to warn about the risks of NEC in premature infants
  • Marketed products for use in vulnerable populations without adequate safety information
  • Continued to promote formulas despite clinical data indicating harm

These lawsuits are part of a growing effort to hold companies accountable for decisions that may have contributed to serious harm in NICU settings.

Who May Qualify for an NEC Lawsuit?

You may be eligible to pursue legal action if:

  • Your child was born prematurely (before 37 weeks)
  • Your child received Similac or Enfamil formula
  • Your child was diagnosed with Necrotizing Enterocolitis (NEC)
  • The diagnosis led to surgery, long-term health complications, or death

Each case is unique, and a qualified attorney can help evaluate whether your situation meets the criteria for an NEC formula claim.

Supporting Families and Raising Awareness

The impact of NEC on families can be profound, both emotionally and medically. Beyond individual legal cases, these lawsuits aim to raise awareness and improve safety standards for infant nutrition, especially for preterm and medically fragile babies.

Legal action can be a way to:

  • Promote better disclosure and accountability from manufacturers
  • Push for changes in hospital feeding protocols
  • Empower parents with critical information when it matters most

At Injury Claim Center, we are committed to connecting families with experienced legal professionals who understand the complexity and sensitivity of NEC-related claims.